Hancock Whitney’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.2M Buy
245,933
+6,273
+3% +$158K 0.1% 164
2026
Q1
$6.06M Buy
239,660
+18,305
+8% +$467K 0.11% 161
2025
Q4
$5.65M Buy
221,355
+2,028
+0.9% +$51.9K 0.1% 159
2025
Q3
$5.62M Buy
219,327
+15,617
+8% +$396K 0.1% 155
2025
Q2
$5.15M Buy
+203,710
New +$5.05M 0.1% 161

Other funds holding IBDX

Hancock Whitney's IBDX Position: Q2 2026 in Review

Hancock Whitney increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 2.6% in Q2 2026, buying an estimated $158K and bringing the position to 245,933 shares worth $6.2M. The position accounts for 0.1% of the portfolio, ranked #164.

Hancock Whitney first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Hancock Whitney held 245,933 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $6.2M as of Q2 2026.
  • Hancock Whitney bought 6,273 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $158K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.1% of Hancock Whitney's portfolio in Q2 2026, its #164 holding.
  • Hancock Whitney first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Hancock Whitney's 13F filing for Q2 2026, filed 14 Aug 2026.